glp 1 and parkinson's disease Glucagon-like peptide-1 medicines in neurological psychiatric disorders: Cell Reports Medicine GLP-1 Signalling as a Therapeutic
Description
Why do surgeons ask about GLP-1 medications

Patients with MS considering tirzepatide therapy should engage in shared decision-making with their healthcare team, including their neurologist and primary care provider or endocrinologist, to ensure coordinated care
342,343,344 The GLP-1R signaling pathway may also affect the expression of MMP-13 and ADAMTS5, by reducing the signal transduction caused by IL-1, thus decreasing their synthesis

Consider these factors: Benefits to discuss: Blood sugar control, weight loss, potential cardiovascular benefits, and possible cancer-protective effects

Since GLP-1s slow digestion, the way you eat becomes more important than ever

When evaluating any compounding pharmacy, ask about their potency testing (do they verify that each batch contains the labeled amount of active ingredient), sterility testing (do they test for microbial contamination), endotoxin testing (do they screen for bacterial toxins), and stability testing (have they verified how long their formulations remain potent under specified storage conditions)
